Discriminative Validity of Strain Elastography of the Supraspinatus Tendon

Sponsor
Karen Brage (Other)
Overall Status
Completed
CT.gov ID
NCT03425344
Collaborator
Odense University Hospital (Other), Sygehus Lillebaelt (Other), Gigtforeningen (Other), Region of Southern Denmark (Other), Radiograf Rådet (Other)
60
1
1
17.3
3.5

Study Details

Study Description

Brief Summary

This study aims at testing the discriminative validity of strain elastography in the normal and abnormal/pathological Supraspinatus tendon due to tendinopathy

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Diagnostic
N/A

Detailed Description

The case-control trial will include 96 participants. 48 of them diagnosed with supraspinatus tendinopathy by MRI and 48 healthy subjects.

In this study the investigators will compare the outcome of tissue elasticity measured by sonoelastography, with MRI and conventional ultrasound.

Patients will be recruited through different radiology department and healthy volunteers will be recruited primarily through advertising in local newspapers and social media.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
A case-control study without interventionA case-control study without intervention
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Discriminative Validity of Real-time Sonoelastography of the Supraspinatus Tendon: Comparison of Findings Between Patients With Supraspinatus Tendinopathy and Healthy Volunteers
Actual Study Start Date :
Mar 11, 2018
Actual Primary Completion Date :
Jul 1, 2019
Actual Study Completion Date :
Aug 21, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: Diagnostic

All participants will be exposed to shoulder- MRI, ultrasound and sonoelastography.

Diagnostic Test: Diagnostic
No traditionally intervention will be given but participants will be exposed to shoulder- MRI, ultrasound and sonoelastography..

Outcome Measures

Primary Outcome Measures

  1. Tendon quality (SEL) [Baseline]

    Sonoelastography - strain elasticity

Secondary Outcome Measures

  1. Pain on a VAS scale [Baseline]

    Change from baseline in Visual Analogue Scale (VAS). Ranging from 0 to 10; 0 being no pain and 10 being severe pain.

  2. Quality of life on the E!-5D-3L questionnaire [Baseline]

    Change in Euro Qol 5D index (EQ-5D-3L). The system consists of a descriptive system and a visual analogue scale (EQ VAS). The descriptive system contains 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Each dimension has 3 levels; no problems, some problems and extreme problems. The EQ-VAS range from 0 (worst imaginable health state) to 100 (best imaginable health state).

  3. Disability [Baseline]

    Change in Disability of the Arm, Shoulder and Hand questionnaire (DASH). Each item is rated with a score from 1 (least disability) to 5 (most disability). All scores are added together, producing a raw score, which is then transformed into a score of 100 maximum. A higher score indicates greater disability.

  4. Tendon quality (MRI) [Baseline]

    Magnetic Resonance

  5. Tendon quality (US) [Baseline]

    Conventional ultrasound

Other Outcome Measures

  1. Demographic [Baseline]

    Gender, age, bmi, education (level), duration of symptoms, symptom history

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Body mass index < 30

  • Symptomatic: Positive on 3/5 clinical tests (full can, empty can, resisted external rotation, neers, hawkins.

  • Asymptomatic: No shoulder pain in the last year, negative on 5/5 clinical tests (full can, empty can, resisted external rotation, neers, hawkins).

Exclusion Criteria:
  • Shoulder-fracture, operation and luxation, known-neuromuscular disease, rheumatoid arthritis, cancer, fibromyalgia, spondyloarthropathy and psychiatric disorders, pregnancy and inability to read and understand Danish. Biceps rupture, labrum lesions, supraspinatus tears (> 1/3 of the vertical tendon height) and calcifications (> 2 mm in length) (MRI).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Southern Denmark Odense Denmark 5230

Sponsors and Collaborators

  • Karen Brage
  • Odense University Hospital
  • Sygehus Lillebaelt
  • Gigtforeningen
  • Region of Southern Denmark
  • Radiograf Rådet

Investigators

  • Study Director: Birgit Juul-Kristensen, Assoc. Prof, Department of Sport Science and Biomechanics

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Karen Brage, Ph.D-student, University of Southern Denmark
ClinicalTrials.gov Identifier:
NCT03425344
Other Study ID Numbers:
  • SEL_Supraspinatus_cross
First Posted:
Feb 7, 2018
Last Update Posted:
Aug 22, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2019